J Psychopharmacol: Most-Cited Full-Text Articles http://jop.sagepub.com/ Most-cited rankings are recalculated at the beginning of the month and are based on citations to articles on this journal site from articles in other HighWire-hosted journals. 2009-11-09 <![CDATA[Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines]]> http://jop.sagepub.com/cgi/content/short/14/1/3?rss=1&ssource=mfc Jan 1, 2000; 14:3-20
Article]]> I. M. Anderson, D. J. Nutt, J. F. W. Deakin 2000-01-01 10.1177/026988110001400101 SAGE Publications <![CDATA[Evidence-Based Guidelines for Treating Bipolar Disorder: Recommendations from the British Association for Psychopharmacology]]> http://jop.sagepub.com/cgi/content/short/17/2/149?rss=1&ssource=mfc Jun 1, 2003; 17:149-173
Article]]> G. M. Goodwin 2003-06-01 10.1177/0269881103017002003 SAGE Publications <![CDATA[5-HT and mechanisms of defence]]> http://jop.sagepub.com/cgi/content/short/5/4/305?rss=1&ssource=mfc Jan 1, 1991; 5:305-315
Article]]> J. F. William Deakin, Frederico G. Graeff 1991-01-01 10.1177/026988119100500414 SAGE Publications <![CDATA[Tryptophan depletion impairs memory consolidation but improves focussed attention in healthy young volunteers]]> http://jop.sagepub.com/cgi/content/short/14/1/21?rss=1&ssource=mfc Jan 1, 2000; 14:21-29
Article]]> Jeroen A. J. Schmitt, Brenda L. Jorissen, Sjacko Sobczak, Martin P. J. van Boxtel, Eef Hogervorst, Nicolaas E. P. Deutz, Wim J. Riedel 2000-01-01 10.1177/026988110001400102 SAGE Publications <![CDATA[Conditioning factors in drug abuse: can they explain compulsion?]]> http://jop.sagepub.com/cgi/content/short/12/1/15?rss=1&ssource=mfc Jan 1, 1998; 12:15-22
Article]]> Charles P. O''Brien, Anna Rose Childress, Ronald Ehrman, Steven J. Robbins 1998-01-01 10.1177/026988119801200103 SAGE Publications <![CDATA[The serotonin syndrome and its treatment]]> http://jop.sagepub.com/cgi/content/short/13/1/100?rss=1&ssource=mfc Jan 1, 1999; 13:100-109
Article]]> P. K. Gillman 1999-01-01 10.1177/026988119901300111 SAGE Publications <![CDATA[Catecholamine regulation of the prefrontal cortex]]> http://jop.sagepub.com/cgi/content/short/11/2/151?rss=1&ssource=mfc Jan 1, 1997; 11:151-162
Article]]> Amy F. T. Arnsten 1997-01-01 10.1177/026988119701100208 SAGE Publications <![CDATA[Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines]]> http://jop.sagepub.com/cgi/content/short/13/2/136?rss=1&ssource=mfc Mar 1, 1999; 13:136-143
Article]]> Rodney L. Dunn, John M. Donoghue, Ronald J. Ozminkowski, Deborah Stephenson, Timothy R. Hylan 1999-03-01 10.1177/026988119901300204 SAGE Publications <![CDATA[Serotonin, stress and corticoids]]> http://jop.sagepub.com/cgi/content/short/14/2/139?rss=1&ssource=mfc Mar 1, 2000; 14:139-151
Article]]> Francis Chaouloff 2000-03-01 10.1177/026988110001400203 SAGE Publications <![CDATA[Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents]]> http://jop.sagepub.com/cgi/content/short/14/2/114?rss=1&ssource=mfc Mar 1, 2000; 14:114-138
Article]]> Mark J. Millan, Francoise Lejeune, Alain Gobert 2000-03-01 10.1177/026988110001400202 SAGE Publications <![CDATA[An evaluation of the abuse potential of modafinil using methylphenidate as a reference]]> http://jop.sagepub.com/cgi/content/short/14/1/53?rss=1&ssource=mfc Jan 1, 2000; 14:53-60
Article]]> Donald R. Jasinski 2000-01-01 10.1177/026988110001400107 SAGE Publications <![CDATA[Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies]]> http://jop.sagepub.com/cgi/content/short/13/4/358?rss=1&ssource=mfc Jul 1, 1999; 13:358-371
Article]]> Marc Laruelle, Anissa Abi-Dargham 1999-07-01 10.1177/026988119901300405 SAGE Publications <![CDATA[Cannabis as a risk factor for psychosis: systematic review]]> http://jop.sagepub.com/cgi/content/short/19/2/187?rss=1&ssource=mfc Mar 1, 2005; 19:187-194
Article]]> David M. Semple, Andrew M. McIntosh, Stephen M. Lawrie 2005-03-01 10.1177/0269881105049040 SAGE Publications <![CDATA[Death and Dependence: Current Controversies over the Selective Serotonin Reuptake Inhibitors]]> http://jop.sagepub.com/cgi/content/short/17/4/355?rss=1&ssource=mfc Dec 1, 2003; 17:355-364
Article]]> David J. Nutt 2003-12-01 10.1177/0269881103174019 SAGE Publications <![CDATA[The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?]]> http://jop.sagepub.com/cgi/content/short/15/1/37?rss=1&ssource=mfc Jan 1, 2001; 15:37-46
Article]]> R. A. Bantick, J. F. W. Deakin, P. M. Grasby 2001-01-01 10.1177/026988110101500108 SAGE Publications <![CDATA[HIV dementia: the role of the basal ganglia and dopaminergic systems]]> http://jop.sagepub.com/cgi/content/short/14/3/214?rss=1&ssource=mfc May 1, 2000; 14:214-221
Article]]> Joseph R. Berger, Gabriele Arendt 2000-05-01 10.1177/026988110001400304 SAGE Publications <![CDATA[Rapid depletion of plasma tryptophan: a review of studies and experimental methodology]]> http://jop.sagepub.com/cgi/content/short/11/4/381?rss=1&ssource=mfc Jan 1, 1997; 11:381-392
Article]]> J.G. Reilly, S.F.B. McTavish, A.H. Young 1997-01-01 10.1177/026988119701100416 SAGE Publications <![CDATA[The neural substrates of sensorimotor gating of the startle reflex: a review of recent findings and their implications]]> http://jop.sagepub.com/cgi/content/short/6/2/176?rss=1&ssource=mfc Jan 1, 1992; 6:176-190
Article]]> N.R. Swerdlow, S.B. Caine, D.L. Braff, M.A. Geyer 1992-01-01 10.1177/026988119200600210 SAGE Publications <![CDATA[Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology]]> http://jop.sagepub.com/cgi/content/short/19/6/567?rss=1&ssource=mfc Nov 1, 2005; 19:567-596
Article]]> David S. Baldwin, Ian M. Anderson, David J. Nutt, Borwin Bandelow, A. Bond, Jonathan R. T. Davidson, J. A. den Boer, Naomi A. Fineberg, Martin Knapp, J. Scott, H. -U. Wittchen 2005-11-01 10.1177/0269881105059253 SAGE Publications <![CDATA[Effects of clonidine and diazepam on the acoustic startle response and on its inhibition by 'prepulses' in man]]> http://jop.sagepub.com/cgi/content/short/11/1/29?rss=1&ssource=mfc Jan 1, 1997; 11:29-34
Article]]> K.A.J. Abduljawad, R.W. Langley, C.M. Bradshaw, E. Szabadi 1997-01-01 10.1177/026988119701100110 SAGE Publications <![CDATA[Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms]]> http://jop.sagepub.com/cgi/content/short/15/3/181?rss=1&ssource=mfc May 1, 2001; 15:181-186
Article]]> N. MacInnes, S. L. Handley, G. F. A. Harding 2001-05-01 10.1177/026988110101500310 SAGE Publications <![CDATA[Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits]]> http://jop.sagepub.com/cgi/content/short/12/1/79?rss=1&ssource=mfc Jan 1, 1998; 12:79-83
Article]]> A.C. Parrott, A. Lees, N.J. Garnham, M. Jones, K. Wesnes 1998-01-01 10.1177/026988119801200110 SAGE Publications <![CDATA[The SSRI discontinuation syndrome]]> http://jop.sagepub.com/cgi/content/short/12/3/305?rss=1&ssource=mfc Jan 1, 1998; 12:305-313
Article]]> Peter Haddad 1998-01-01 10.1177/026988119801200311 SAGE Publications <![CDATA[Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic caseseries outcome study]]> http://jop.sagepub.com/cgi/content/short/15/4/297?rss=1&ssource=mfc Jul 1, 2001; 15:297-301
Article]]> S. M. Dursun, J. F. W. Deakin 2001-07-01 10.1177/026988110101500409 SAGE Publications <![CDATA[Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug]]> http://jop.sagepub.com/cgi/content/short/15/4/273?rss=1&ssource=mfc Jul 1, 2001; 15:273-281
Article]]> H. C. Fox, A. C. Parrott, J. J. D. Turner 2001-07-01 10.1177/026988110101500406 SAGE Publications <![CDATA[Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors]]> http://jop.sagepub.com/cgi/content/short/15/3/173?rss=1&ssource=mfc May 1, 2001; 15:173-179
Article]]> Jeroen A. J. Schmitt, Monique J. Kruizinga, Wim J. Riedel 2001-05-01 10.1177/026988110101500304 SAGE Publications <![CDATA[Comparison of the effects of diazepam on the fear-potentiated startle reflex and the fear-inhibited light reflex in man]]> http://jop.sagepub.com/cgi/content/short/13/3/226?rss=1&ssource=mfc May 1, 1999; 13:226-234
Article]]> P. Bitsios, A. Philpott, R. W. Langley, C. M. Bradshaw, E. Szabadi 1999-05-01 10.1177/026988119901300303 SAGE Publications <![CDATA[Impulsivity: a discussion of clinical and experimental findings]]> http://jop.sagepub.com/cgi/content/short/13/2/180?rss=1&ssource=mfc Mar 1, 1999; 13:180-192
Article]]> John Evenden 1999-03-01 10.1177/026988119901300211 SAGE Publications <![CDATA[Serotonin autoreceptor function and antidepressant drug action]]> http://jop.sagepub.com/cgi/content/short/14/2/177?rss=1&ssource=mfc Mar 1, 2000; 14:177-185
Article]]> S. Hjorth, H. J. Bengtsson, A. Kullberg, D. Carlzon, H. Peilot, S. B. Auerbach 2000-03-01 10.1177/026988110001400208 SAGE Publications <![CDATA[The compliance with antidepressants in general practice]]> http://jop.sagepub.com/cgi/content/short/8/1/48?rss=1&ssource=mfc Jan 1, 1994; 8:48-52
Article]]> J.C. Maddox, M. Levi, C. Thompson 1994-01-01 10.1177/026988119400800108 SAGE Publications <![CDATA[Does the Brain Noradrenaline Network Mediate the Effects of the CO2 Challenge?]]> http://jop.sagepub.com/cgi/content/short/17/3/252?rss=1&ssource=mfc Sep 1, 2003; 17:252-259
Article]]> J. E. Bailey, S. V. Argyropoulos, S. L. Lightman, D. J. Nutt 2003-09-01 10.1177/02698811030173002 SAGE Publications <![CDATA[Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man]]> http://jop.sagepub.com/cgi/content/short/12/3/239?rss=1&ssource=mfc Jan 1, 1998; 12:239-245
Article]]> K.A.J. Abduljawad, R.W. Langley, C.M. Bradshaw, E. Szabadi 1998-01-01 10.1177/026988119801200302 SAGE Publications <![CDATA[Effects of bromocriptine and haloperidol on prepulse inhibition: comparison of the acoustic startle eyeblink response and the N1/P2 auditory-evoked response in man]]> http://jop.sagepub.com/cgi/content/short/13/1/3?rss=1&ssource=mfc Jan 1, 1999; 13:3-9
Article]]> K. A. J. Abduljawad, R. W. Langley, C. M. Bradshaw, E. Szabadi 1999-01-01 10.1177/026988119901300101 SAGE Publications <![CDATA[Selective cognitive processing of drug cues in heroin dependence]]> http://jop.sagepub.com/cgi/content/short/14/4/395?rss=1&ssource=mfc Jul 1, 2000; 14:395-400
Article]]> Ingmar H. A. Franken, Linda Y. Kroon, Reinout W. Wiers, Anita Jansen 2000-07-01 10.1177/026988110001400408 SAGE Publications <![CDATA[The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3, 4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers]]> http://jop.sagepub.com/cgi/content/short/14/3/269?rss=1&ssource=mfc May 1, 2000; 14:269-274
Article]]> Matthias E. Liechti, Franz X. Vollenweider 2000-05-01 10.1177/026988110001400313 SAGE Publications <![CDATA[SSRI-Induced extrapyramidal side-effects and akathisia: implications for treatment]]> http://jop.sagepub.com/cgi/content/short/12/2/192?rss=1&ssource=mfc Jan 1, 1998; 12:192-214
Article]]> Roger M. Lane 1998-01-01 10.1177/026988119801200212 SAGE Publications <![CDATA[Ecstasy: Are animal data consistent between species and can they translate to humans?]]> http://jop.sagepub.com/cgi/content/short/20/2/194?rss=1&ssource=mfc Mar 1, 2006; 20:194-210
Article]]> Neil Easton, Charles A. Marsden 2006-03-01 10.1177/0269881106061153 SAGE Publications <![CDATA[The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview]]> http://jop.sagepub.com/cgi/content/short/20/2/188?rss=1&ssource=mfc Mar 1, 2006; 20:188-193
Article]]> Euphrosyne Gouzoulis-Mayfrank, Jorg Daumann 2006-03-01 10.1177/0269881106059939 SAGE Publications <![CDATA[Receptor Mechanisms in the treatment of Schizophrenia]]> http://jop.sagepub.com/cgi/content/short/18/3/340?rss=1&ssource=mfc Sep 1, 2004; 18:340-345
Article]]> Gavin P. Reynolds 2004-09-01 10.1177/026988110401800303 SAGE Publications <![CDATA[Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology]]> http://jop.sagepub.com/cgi/content/short/18/3/293?rss=1&ssource=mfc Sep 1, 2004; 18:293-335
Article]]> A. R. Lingford-Hughes, S. Welch, D. J. Nutt 2004-09-01 10.1177/026988110401800321 SAGE Publications <![CDATA[Dopamine, the prefrontal cortex and schizophrenia]]> http://jop.sagepub.com/cgi/content/short/11/2/123?rss=1&ssource=mfc Jan 1, 1997; 11:123-131
Article]]> Michael B. Knable, Daniel R. Weinberger 1997-01-01 10.1177/026988119701100205 SAGE Publications <![CDATA[Suicide and schizophrenia]]> http://jop.sagepub.com/cgi/content/short/15/2/127?rss=1&ssource=mfc Mar 1, 2001; 15:127-135
Article]]> Samuel G. Siris 2001-03-01 10.1177/026988110101500209 SAGE Publications <![CDATA[Suicide in the course of the treatment of depression]]> http://jop.sagepub.com/cgi/content/short/13/1/94?rss=1&ssource=mfc Jan 1, 1999; 13:94-99
Article]]> D. Healy, C. Langmaak, M. Savage 1999-01-01 10.1177/026988119901300110 SAGE Publications <![CDATA[Psychotropic drugs in mothers' milk: a comprehensive review of assay methods, pharmacokinetics and of safety of breast-feeding]]> http://jop.sagepub.com/cgi/content/short/13/1/64?rss=1&ssource=mfc Jan 1, 1999; 13:64-80
Article]]> K. Yoshida, B. Smith, R. Kumar 1999-01-01 10.1177/026988119901300108 SAGE Publications <![CDATA[effects of d-amphetamine and haloperidol on latent inhibition in healthy male volunteers]]> http://jop.sagepub.com/cgi/content/short/13/4/398?rss=1&ssource=mfc Jul 1, 1999; 13:398-405
Article]]> Veena Kumari, Paul A. Cotter, Owen F. Mulligan, Stuart A. Checkley, Nicola S. Gray, David R. Hemsley, Jasper C. Thornton, Philip J. Corr, Brian K. Toone, Jeffrey A. Gray 1999-07-01 10.1177/026988119901300411 SAGE Publications <![CDATA[Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans]]> http://jop.sagepub.com/cgi/content/short/13/4/337?rss=1&ssource=mfc Jul 1, 1999; 13:337-345
Article]]> Nora D. Volkow, Joanna S. Fowler, Gene-Jack Wang 1999-07-01 10.1177/026988119901300406 SAGE Publications <![CDATA[Review: Glutamate and dopamine dysregulation in schizophrenia a synthesis and selective review]]> http://jop.sagepub.com/cgi/content/short/21/4/440?rss=1&ssource=mfc Jun 1, 2007; 21:440-452
Article]]> James M. Stone, Paul D. Morrison, Lyn S. Pilowsky 2007-06-01 SAGE Publications <![CDATA[Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study]]> http://jop.sagepub.com/cgi/content/short/20/2/226?rss=1&ssource=mfc Mar 1, 2006; 20:226-235
Article]]> Maartje M. L. de Win, Thelma Schilt, Liesbeth Reneman, Hylke Vervaeke, Gerry Jager, Sarah Dijkink, Jan Booij, Wim van den Brink 2006-03-01 10.1177/0269881106063275 SAGE Publications <![CDATA[Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective]]> http://jop.sagepub.com/cgi/content/short/20/2/211?rss=1&ssource=mfc Mar 1, 2006; 20:211-225
Article]]> R. Thomasius, P. Zapletalova, K. Petersen, R. Buchert, B. Andresen, L. Wartberg, B. Nebeling, A. Schmoldt 2006-03-01 10.1177/0269881106059486 SAGE Publications <![CDATA[Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?]]> http://jop.sagepub.com/cgi/content/short/19/6_suppl/47?rss=1&ssource=mfc Nov 1, 2005; 19:47-55
Article]]> Stephen C. L. Gough, Michael C. O''Donovan 2005-11-01 10.1177/0269881105058380 SAGE Publications